Similarly, adenovirus-based therapies, such as ADV/HSV-tk combined with radiation therapy, achieved clinical benefit in both PD-1-naive and PD-1-resistant NSCLC [82]. The gene discussed is TKT; the disease is non-small cell lung carcinoma.